| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0064 | 0.9 |